Report Tools

Biotechnology in the Netherlands

Published: August 2013 · Publisher: MarketLine
Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017).
Report Type Industry Profiles
Language English
Format Electronic (PDF)
Pages30
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6785
Price € 259,00
Options
  • Description
  • Companies Mentioned
  • Table of Contents
  • Ask a Question
Introduction

Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

*The Dutch biotechnology market had total revenues of $358.2m in 2012, representing a compound annual growth rate (CAGR) of 3.3% between 2008 and 2012.

*In 2012 many companies in Europe were still preoccupied with matters of efficiency and raising funds in a difficult financing environment. These though conditions are however expected to ease going forward, which should facilitate good market growth.

*The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.8% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $452.1m by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the Netherlands

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the Netherlands

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Netherlands economy

Key Questions Answered

What was the size of the Netherlands biotechnology market by value in 2012?

What will be the size of the Netherlands biotechnology market in 2017?

What factors are affecting the strength of competition in the Netherlands biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up the Netherlands's biotechnology market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Actelion Ltd, Biogen Idec, Inc. and Crucell N.V.
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Actelion Ltd 19
Biogen Idec, Inc. 22
Crucell N.V. 25
Macroeconomic Indicators 26
Country Data 26
Appendix 28
Methodology 28
Industry associations 29
Related research 29

LIST OF TABLES
Table 1: Netherlands biotechnology market value: $ million, 2008–12 8
Table 2: Netherlands biotechnology market category segmentation: $ million, 2012 9
Table 3: Netherlands biotechnology market geography segmentation: $ million, 2012 10
Table 4: Netherlands biotechnology market value forecast: $ million, 2012–17 11
Table 5: Actelion Ltd: key facts 19
Table 6: Actelion Ltd: key financials ($) 20
Table 7: Actelion Ltd: key financials (CHF) 20
Table 8: Actelion Ltd: key financial ratios 20
Table 9: Biogen Idec, Inc.: key facts 22
Table 10: Biogen Idec, Inc.: key financials ($) 23
Table 11: Biogen Idec, Inc.: key financial ratios 23
Table 12: Crucell N.V.: key facts 25
Table 13: Netherlands size of population (million), 2008–12 26
Table 14: Netherlands gdp (constant 2000 prices, $ billion), 2008–12 26
Table 15: Netherlands gdp (current prices, $ billion), 2008–12 26
Table 16: Netherlands inflation, 2008–12 27
Table 17: Netherlands consumer price index (absolute), 2008–12 27
Table 18: Netherlands exchange rate, 2008–12 27

LIST OF FIGURES
Figure 1: Netherlands biotechnology market value: $ million, 2008–12 8
Figure 2: Netherlands biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: Netherlands biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: Netherlands biotechnology market value forecast: $ million, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in the Netherlands, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in the Netherlands, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in the Netherlands, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in the Netherlands, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in the Netherlands, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in the Netherlands, 2012 18
Figure 11: Actelion Ltd: revenues & profitability 21
Figure 12: Actelion Ltd: assets & liabilities 21
Figure 13: Biogen Idec, Inc.: revenues & profitability 23
Figure 14: Biogen Idec, Inc.: assets & liabilities 24
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.